- COVID-19
vaccine candidate developed by
United Biomedical Asia [zh], and
Vaxxinity, Inc. It is a
peptide vaccine. It is
composed of SARS-CoV-2 S1-RBD protein...
- Lou Reese, as a
subsidiary of
United Biomedical Inc. (UBI).
COVAXX (now
Vaxxinity ) is the
developer of the UB-612 COVID-19
vaccine candidate. In 2012,...
- for the
treatment of Alzheimer's disease. It is
under development by
Vaxxinity.
Meningoencephalitis has been
described as a
possible side
effect of the...
-
authority positions. Wang’s
daughter Mei Mei Hu is the co-founder and CEO of
Vaxxinity (originally
named Covaxx), a
subsidiary of UBI; the
company originally...
-
early investor in
several companies including Galaxy Interactive, A16z,
Vaxxinity,
Bulletproof Coffee, Colossal, 1UP Ventures, SALT, Limeade, Deviation...
- Jun 2021,
Vietnam Emergency (1)
Vietnam UB-612
United Biomedical,Inc,
Vaxxinity, DASA Brazil, Taiwan,
United States Subunit (Multitope
peptide based S1-RBD-protein...
- States,
Netherlands phase III
clinical trials 10 June 2021
Pending UB-612
Vaxxinity (formerly COVAXX), and DASA
United Biomedical, Inc. Asia [zh]
Taiwan phase...
